Skip to content

The Study of Wuling Capsule in Treatment Chronic Tinnitus

Clinical Study of Wuling Capsule in the Treatment of Chronic Tinnitus With Emotional Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03674853
Enrollment
59
Registered
2018-09-18
Start date
2018-06-12
Completion date
2020-03-30
Last updated
2022-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus, Subjective

Brief summary

To evaluate the effect of psychological/mental factors on the severity of subjective tinnitus, to observe the efficacy and safety of Wuling capsule in the treatment of chronic subjective tinnitus with emotional disorders, and to evaluate the control rate of tinnitus complications, such as depression, anxiety and insomnia, and the improvement of patients'quality of life.

Detailed description

To evaluate the effect of psychological/mental factors on the severity of subjective tinnitus, to observe the efficacy and safety of Wuling capsule in the treatment of chronic subjective tinnitus with emotional disorders, and to evaluate the control rate of tinnitus complications, such as depression, anxiety and insomnia, and the improvement of patients'quality of life. Patients with chronic tinnitus complicated with mild to moderate anxiety or depression were randomly divided into two groups. The experimental group was given oral treatment with Wuling capsule, and the control group was given gurusu treatment. The improvement of tinnitus, sleep, anxiety and depression in patients was evaluated at 2,4 and 8 weeks after treatment, respectively, and the efficacy of Wuling capsule in improving tinnitus combined with anxiety, depression and tinnitus was analyzed。

Interventions

take Wuling Capsule in experiment group for 2 months

DRUGOryzanol

take oryzanol in active comparator group for 2 months

Sponsors

Xijing Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Tinnitus with a history longer than 6 months; * 7 \< HAMD score \< 24 and / or 7 \< HAMA score \< 21; * No antianxiety, depression or antipsychotic treatment within 2 weeks.

Exclusion criteria

* objective tinnitus; * tinnitus with defined causes; * accompanied with acute infection, acute trauma, perioperative, chronic disease in the acute stage; * with mental illness family history; * HAMD score greater than 24 points or HAMA score greater than 21 points;

Design outcomes

Primary

MeasureTime frameDescription
the change of severity of tinnitus8 weekstinnitus handicap index is to evaluate the severity of tinnitus

Secondary

MeasureTime frameDescription
the change of anxiety level8 weeksHamilton anxiety scale is to evaluate the anxiety level
the change of depression level8 weeksHamilton depression scale is to evaluate the depression level

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026